A scaled-down MRI process can detect prostate cancers more quickly and at a lower cost than the current standard approach while maintaining similar accuracy, according to a peer-reviewed study published on Sept. 10 by the journal JAMA.
The study compared two types of MRI used to detect prostate cancer: biparametric and multiparametric, according to a statement from University College London (UCL), one of the institutions involved in the research.